17-41571505-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000226.4(KRT9):c.488G>A(p.Arg163Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000031 in 1,613,774 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R163P) has been classified as Uncertain significance.
Frequency
Consequence
NM_000226.4 missense
Scores
Clinical Significance
Conservation
Publications
- epidermolytic palmoplantar keratoderma, 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151894Hom.: 0 Cov.: 31 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461880Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 727240 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151894Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74146 show subpopulations
ClinVar
Submissions by phenotype
Palmoplantar keratoderma, epidermolytic Pathogenic:4
- -
PS4, PP1, PP3, PM1, PM2, PM5, PM6 -
PM1, PM2, PP2, PP3, PP5 -
The variant is not observed in the gnomAD v2.1.1 dataset. It is located in a mutational hot spot and/or well-established functional domain in which established pathogenic variants have been reported. Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.83; 3Cnet: 0.87). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000003001). A different missense change at the same codon (p.Arg163Trp) has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000002997). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
not provided Pathogenic:2Other:1
- -
Located within the helix initiation motif in the 1A domain, a region intolerant to change (Chamcheu et al., 2011); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; In silico analysis, which includes splice predictors, suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 22678789, 22584502, 7512862, 24862219, 22402445, 31074163, 22262370, 33914963, 19874353, 30666268) -
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 163 of the KRT9 protein (p.Arg163Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with epidermolytic palmoplantar keratoderma (PMID: 30666268, 33914963). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 3001). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KRT9 protein function with a positive predictive value of 80%. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This variant disrupts the p.Arg163 amino acid residue in KRT9. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 22262370). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Inborn genetic diseases Pathogenic:1
- -
Epidermolytic palmoplantar keratoderma, 1 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at